MEET OUR TEAM
Dr Sid O'Bryant, Ph.D.
Founder & Chief Executive Officer
Dr. Sid O'Bryant is a global leader in blood biomarkers of Alzheimer's disease, brain aging and neurodegeneration. A Key Opinion Leader across multiple facets of brain aging. He is also a serial inventor and entrepreneur - CEO/Executive Director - Institute for Translational Research, Founding Scientists - Cx Precision Medicine, CEO/Founder/Inventor - Cerebrolift, multiple patent families licensed.
Winnie Pak, PhD, is a clinical and medical affairs executive with over 20 years of accelerating drug development across neuroscience and rare disease. A recognized expert in trial recruitment and stakeholder engagement, she has led global strategies in Alzheimer's and supported IND-to-NDA success through cross-functional leadership. She holds a PhD in Neurosciences from UC San Diego and The Salk Institute.
Kelly Berry, MBA, is a financial strategist and research operations leader with over 25 years of experience managing large-scale budgets, research infrastructure, and institutional growth. As Deputy Director of Finance at the UNT Health's Institute for Translational Research, she directed $50M in annual research expenditures and helped launch a clinical research center now generating $9.7M in annual revenue. Previously, she oversaw an $80M+ annual budget for the Research Division at the University of Houston. Now serving as Chief Financial Officer, Kelly bridges the worlds of science and business — bringing rigor, clarity, and strategic focus to building the operational foundation that moves Alzheimer's and dementia research from the lab to the lives of patients.